Tirzepatide is a novel glucose-dependent insulinotropic polypeptide and GLP-1 agonist with substantial benefits in patients with type 2 diabetes and obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.